325 related articles for article (PubMed ID: 16226778)
1. Effect of Ginkgo biloba extract on procarcinogen-bioactivating human CYP1 enzymes: identification of isorhamnetin, kaempferol, and quercetin as potent inhibitors of CYP1B1.
Chang TK; Chen J; Yeung EY
Toxicol Appl Pharmacol; 2006 May; 213(1):18-26. PubMed ID: 16226778
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of human CYP2B6-catalyzed bupropion hydroxylation by Ginkgo biloba extract: effect of terpene trilactones and flavonols.
Lau AJ; Chang TK
Drug Metab Dispos; 2009 Sep; 37(9):1931-7. PubMed ID: 19487249
[TBL] [Abstract][Full Text] [Related]
3. Effect of Ginkgo biloba extract on rat hepatic microsomal CYP1A activity: role of ginkgolides, bilobalide, and flavonols.
Kuo If; Chen J; Chang TK
Can J Physiol Pharmacol; 2004 Jan; 82(1):57-64. PubMed ID: 15052306
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of procarcinogen-bioactivating human CYP1A1, CYP1A2 and CYP1B1 enzymes by melatonin.
Chang TK; Chen J; Yang G; Yeung EY
J Pineal Res; 2010 Jan; 48(1):55-64. PubMed ID: 19919601
[TBL] [Abstract][Full Text] [Related]
5. Modulation of CYP1B1 and CYP1A1 gene expression and activation of aryl hydrocarbon receptor by Ginkgo biloba extract in MCF-10A human mammary epithelial cells.
Rajaraman G; Yang G; Chen J; Chang TK
Can J Physiol Pharmacol; 2009 Sep; 87(9):674-83. PubMed ID: 19794518
[TBL] [Abstract][Full Text] [Related]
6. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1.
Chang TK; Chen J; Benetton SA
Drug Metab Dispos; 2002 Apr; 30(4):378-84. PubMed ID: 11901090
[TBL] [Abstract][Full Text] [Related]
7. Effect of Ginkgo biloba extract on oxidative metabolism of valproic acid in hepatic microsomes from donors with the CYP2C9*1/*1 genotype.
Numa AM; Abbott FS; Chang TK
Can J Physiol Pharmacol; 2007 Sep; 85(9):848-55. PubMed ID: 18066130
[TBL] [Abstract][Full Text] [Related]
8. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
Chang TK; Chen J; Lee WB
J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
[TBL] [Abstract][Full Text] [Related]
9. Modulation of CYP1A1 activity by a Ginkgo biloba extract in the human intestinal Caco-2 cells.
Ribonnet L; Callebaut A; Nobels I; Scippo ML; Schneider YJ; De Saeger S; Pussemier L; Larondelle Y
Toxicol Lett; 2011 May; 202(3):193-202. PubMed ID: 21329749
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of human cytochromes P450 by components of Ginkgo biloba.
von Moltke LL; Weemhoff JL; Bedir E; Khan IA; Harmatz JS; Goldman P; Greenblatt DJ
J Pharm Pharmacol; 2004 Aug; 56(8):1039-44. PubMed ID: 15285849
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of CYP1 by berberine, palmatine, and jatrorrhizine: selectivity, kinetic characterization, and molecular modeling.
Lo SN; Chang YP; Tsai KC; Chang CY; Wu TS; Ueng YF
Toxicol Appl Pharmacol; 2013 Nov; 272(3):671-80. PubMed ID: 23886934
[TBL] [Abstract][Full Text] [Related]
12. Characterization of major phytocannabinoids, cannabidiol and cannabinol, as isoform-selective and potent inhibitors of human CYP1 enzymes.
Yamaori S; Kushihara M; Yamamoto I; Watanabe K
Biochem Pharmacol; 2010 Jun; 79(11):1691-8. PubMed ID: 20117100
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
[TBL] [Abstract][Full Text] [Related]
14. Potent inhibition of carcinogen-bioactivating cytochrome P450 1B1 by the p53 inhibitor pifithrin alpha.
Sparfel L; Van Grevenynghe J; Le Vee M; Aninat C; Fardel O
Carcinogenesis; 2006 Mar; 27(3):656-63. PubMed ID: 16258175
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of intestinal and hepatic glucuronidation of mycophenolic acid by Ginkgo biloba extract and flavonoids.
Mohamed MF; Frye RF
Drug Metab Dispos; 2010 Feb; 38(2):270-5. PubMed ID: 19889883
[TBL] [Abstract][Full Text] [Related]
16. Oxidation of xenobiotics by recombinant human cytochrome P450 1B1.
Shimada T; Gillam EM; Sutter TR; Strickland PT; Guengerich FP; Yamazaki H
Drug Metab Dispos; 1997 May; 25(5):617-22. PubMed ID: 9152602
[TBL] [Abstract][Full Text] [Related]
17. Effects of hydroxyl group numbers on the B-ring of 5,7-dihydroxyflavones on the differential inhibition of human CYP 1A and CYP1B1 enzymes.
Kim HJ; Lee SB; Park SK; Kim HM; Park YI; Dong MS
Arch Pharm Res; 2005 Oct; 28(10):1114-21. PubMed ID: 16276964
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of human cytochrome P450 1A1-, 1A2-, and 1B1-mediated activation of procarcinogens to genotoxic metabolites by polycyclic aromatic hydrocarbons.
Shimada T; Guengerich FP
Chem Res Toxicol; 2006 Feb; 19(2):288-94. PubMed ID: 16485905
[TBL] [Abstract][Full Text] [Related]
19. Further assessment of 17alpha-ethinyl estradiol as an inhibitor of different human cytochrome P450 forms in vitro.
Chang SY; Chen C; Yang Z; Rodrigues AD
Drug Metab Dispos; 2009 Aug; 37(8):1667-75. PubMed ID: 19454483
[TBL] [Abstract][Full Text] [Related]
20. VERIFICATION OF AUTHENTICITY OF
Budeč M; Bošnir J; Racz A; Lasić D; Brkić D; Mosović Ćuić A; Kuharić Ž; Jurak G; Barušić L
Acta Clin Croat; 2019 Dec; 58(4):672-692. PubMed ID: 32595253
[No Abstract] [Full Text] [Related]
[Next] [New Search]
